<DOC>
	<DOC>NCT01704638</DOC>
	<brief_summary>The investigators will compare plasma kinetics of two marker drugs in individuals with different genetic variations in the MDR1-gene. The hypothesis is that one group will have higher exposure than the other.</brief_summary>
	<brief_title>Kinetics of Fluvoxamine and Digoxin in Subjects With Different MDR1 Genotypes</brief_title>
	<detailed_description />
	<mesh_term>Digoxin</mesh_term>
	<mesh_term>Fluvoxamine</mesh_term>
	<criteria>Healthy volunteer ≥ 18 years of age Normal kidney function as measured by GFR according to CockroftGault (70120 ml/min) Normal Ppotassiumvalue (3,64,6 mmol/L) HF&gt;50 and no AVblock on resting ECG. No other significant abnormalities as judged by the investigator. Subject giving written informed consent Subject capable of understanding instructions Pregnancy Ongoing infection Intake of medication, including natural remedies (for example St John´s wort), within one month prior to starting study except for paracetamol. Active drug or alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>